64 results
Page 3 of 4
6-K
EX-99.1
1dvvj
17 Apr 13
Data Reported Comparable Multiple Pregnancy Rates Among Patients Treated with Investigational Milprosa™ and Progesterone Vaginal Gel
12:00am
6-K
EX-99.1
837kr
26 Oct 12
Teva Receives Approval for Synribotm(omacetaxine Mepesuccinate) for Injection
12:00am
6-K
EX-99.1
znarop
25 Oct 12
Live Filing
12:00am
6-K
EX-99.1
423 fol8q0tlk8bhr
25 Oct 12
Live Filing
12:00am
6-K
EX-99.1
etp41 acn
18 Oct 12
Teva Women’s Health, Inc. to Present New Data at the 68th Annual Meeting of the American Society for Reproductive Medicine
12:00am
6-K
EX-99.1
963sa3n as
2 Jul 12
Teva Announces Progress of Biologic Investigational Drugs Evaluated to Treat Neutropenia In Breast Cancer Patients Undergoing Chemotherapy
12:00am
6-K
EX-99.1
7xkfwso
8 May 12
Teva Appoints Michael Hayden as President of Global Research and Development and Chief Scientific Officer
12:00am
6-K
1ams4
4 Aug 11
Current report (foreign)
12:00am
6-K
eoj778pj9 syjx7
31 May 11
Teva Announces Data on Granulocyte Colony Stimulating Factor Compounds for the Prevention of Chemotherapy-induced Neutropenia In Breast Cancer Patients
12:00am
6-K
mw12jkwr
19 May 11
Teva and Oncogenex to Present Data on Custirsen In Prostate Cancer at the 2011 Asco Annual Meeting
12:00am
6-K
lcgp2dr
19 Jan 11
Teva Congratulates Professor Moussa Youdim, Winner of the 2010 Emet Prize for Brain Science
12:00am
6-K
m729sj6
18 May 10
Current report (foreign)
12:00am
6-K
qjl6bi ryl56tve
17 Feb 09
Oral Laquinimod for Multiple Sclerosis Granted Fast Track Status by Fda
12:00am
6-K
ww6geo4b
24 Sep 08
Teva???s Proair? Hfa, the Market Leading Albuterol Inhaler, Receives New Pediatric Indication - Printer Friendly Version
12:00am
6-K
zy09fi3y j7
23 May 08
Current report (foreign)
12:00am